Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00053143.xml
Download PDF
CC BY 4.0 · Chinese medicine and natural products 2025; 05(01): e23-e29
DOI: 10.1055/s-0045-1807255
DOI: 10.1055/s-0045-1807255
Review Article
Research Progress on the Role of Puerarin in the Prevention and Treatment of Alzheimer's Disease
Funding This work was supported by the National Natural Science Foundation of China (82274612), Key Research Project of the Henan Academy of Chinese Medical Sciences (2024Y1031), Henan Province Key Research and Development and Promotion Special Project (Science and Technology Research) (232102310505), Henan Province University Science and Technology Innovation Talents Program (23HASTIT044), and Henan University of Chinese Medicine Scientific Research Seedling Project (MP2023-08, MP2023-22).
Abstract
Alzheimer's disease (AD) is a neurodegenerative disease that affects cognitive abilities in the elderly. Puerarin plays an important role in the prevention and treatment of AD. It exerts potential therapeutic effects in multiple aspects, including regulating the expression of amyloid β-protein (Aβ), inhibiting abnormal phosphorylation of microtubule-associated protein-τ (Tau), scavenging free radicals, resisting oxidation, regulating metal metabolism to maintain cholinergic system stability, improving mitochondrial dysfunction, and resisting inflammation. However, the specific mechanisms by which puerarin protects cortical neurons in the brain are not fully explored. Hypothetical therapeutic pathways still require further scientific verification.
CRediT Authorship Contribution Statement
Changsong Chu: Project administration and validation. Yaquan Jia: Conceptualization, data curation, and writing—original draft. Yuan Liu: Data curation, methodology, and writing—review and editing. Ruofei Du: Data curation and software. Zichuang Wang: Methodology and writing—review and editing. Zhenqiang Zhang: Formal analysis and investigation. Wanchun Zheng: validation. Junying Song: Data curation.
Publication History
Received: 08 November 2024
Accepted: 12 January 2025
Article published online:
08 April 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Lopez JaS, Gonzalez HM, Leger GC. Alzheimer's disease. Handb Clin Neurol 2019; 167: 231-255
- 2 Li Y, Li H, Li HP. et al. Effects of memantine combined with donepezil in treatment of patients with Alzheimer's disease. Med J Chin People's Health 2024; 36 (13) 37-40
- 3 Philip S, Bart DS, Miia K. et al. Alzheimer's disease. Lancet 2021; 397 (10284): 1577-1590
- 4 Wang H, Dong B, Chang PS. et al. Research on the medicinal properties and functions of Pueraria lobata . Guid J Tradit Chin Med Pharm 2016; 22 (19) 75-77
- 5 Li R, Song ZL, Zhang XK. et al. Research progress of modern pharmacological effects of Pueraria lobata and its compound clinical application. J Hainan Med Coll 2023; (02) 153-160
- 6 Li R, Hao XL, Liu JC. et al. Progress in the mechanism of improving cardiovascular disease by Pueraria puerariae and its active components. Ginseng Res 2021; 33 (04) 59-61
- 7 Xu HX, Li Q, Wang YM. Research progress of puerarin in treatment of Alzheimer's disease. Zhonghua Zhongyiyao Xuekan 2023; 41 (05) 29-33
- 8 Zhang H, Wang Y, Zhang XN. et al. Discuss Lewy body dementia from the perspective of cerebral marrow-brain-brain-brain. Global Tradit Chin Med 2023; 16 (10) 2051-2054
- 9 Zhang S, Wei Y, Li H. Central nervous system regeneration of patients with Alzheimer's disease: Based on the kidney-brain related theory. J Tradit Chin Med 2018; 59 (02) 120-123
- 10 Rostagno AA. Pathogenesis of Alzheimer's disease. Int J Mol Sci 2022; 24 (01) 107
- 11 Gouras GK, Olsson TT, Hansson O. β-Amyloid peptides and amyloid plaques in Alzheimer's disease. Neurotherapeutics 2015; 12 (01) 3-11
- 12 Wang GQ, Cao YP. Advances in the study of Aβ oligomers and Alzheimer's disease. J Apoplexy Nerv Dis 2023; 40 (07) 579-583
- 13 Yao Y, Bao YT, Wu YS. et al. Influence of puerarin on the level of Tau hyperphosphorylation and β-amyloid peptide 40/42 protein expression induced by β-amyloid peptide 1–42 in SH-SY5Y cells. Chin J Clin Pharmacol Ther 2016; (11) 1258-1262
- 14 Mei ZR, Tan XP, Huang HH. et al. Puerarin against Alzheimer's disease by inhibition β-amyloid protein. Chin J Mod Appl Pharm 2015; (01) 5-9
- 15 Zhang HY, Yi XN, Liu YH, Lao ML, Zhang XF. The protective effect of puerarin on Abeta(25-35)-induced PC12 cell injury [in Chinese]. Zhong Yao Cai 2010; 33 (05) 763-767
- 16 Yan FL, Lu G, Wang YQ. et al. Effect of puerarin on the expression of Aβ1–40 and Bax in brain of AD rats induced by Aβ25–35. Chin J Neuromed 2006; 5: 158-161
- 17 Li L, Xue Z, Chen L, Chen X, Wang H, Wang X. Puerarin suppression of Aβ1-42-induced primary cortical neuron death is largely dependent on ERβ. Brain Res 2017; 1657: 87-94
- 18 Lu XL, Liu JX, Wu Q. et al. Protective effects of puerarin against Aβ40-induced vascular dysfunction in zebrafish and human endothelial cells. Eur J Pharmacol 2014; 732: 76-85
- 19 Wegmann S, Biernat J, Mandelkow E. A current view on Tau protein phosphorylation in Alzheimer's disease. Curr Opin Neurobiol 2021; 69: 131-138
- 20 Chen XC. Mechanism of action of puerarin against Alzheimer's disease based on wnt/β-catenin (GSK-3β) pathway. Zhejiang: Zhejiang University of Traditional Chinese Medicine; 2024
- 21 Giovinazzo D, Bursac B, Sbodio JI. et al. Hydrogen sulfide is neuroprotective in Alzheimer's disease by sulfhydrating GSK3β and inhibiting Tau hyperphosphorylation. Proc Natl Acad Sci U S A 2021; 118 (04) e2017225118
- 22 Yao Y, Chen X, Bao Y, Wu Y. Puerarin inhibits β–amyloid peptide 1–42–induced tau hyperphosphorylation via the Wnt/β–catenin signaling pathway. Mol Med Rep 2017; 16 (06) 9081-9085
- 23 Hong XP, Chen T, Yin NN. et al. Puerarin ameliorates D-galactose induced enhanced hippocampal neurogenesis and tau hyperphosphorylation in rat brain. J Alzheimers Dis 2016; 51 (02) 605-617
- 24 Yu YL. Effect of puerarin on tau hyperphosphorylation in the Alzheimer's and type 2 diabetes rat brain and the underlying mechanisms. Wuhan: Hubei University of Traditional Chinese Medicine; 2018
- 25 Hong XP, Chen T, Zhou Z. et al. Effects of puerarin on learning and memory function and phosphorylation level of tau protein in the hippocampus in aged rats. Zhongguo Laonianxue Zazhi 2015; (14) 3802-3805
- 26 Xu ZD. Molecular dynamics study of heat shock protein B5 to inhibit β-amyloid and Tau protein aggregation: a preliminary study on the mechanism of exercise delaying Alzheimer's disease. Shanghai: Shanghai University of Sport; 2024
- 27 Brieger K, Schiavone S, Miller Jr FJ, Krause KH. Reactive oxygen species: from health to disease. Swiss Med Wkly 2012; 142: w13659
- 28 Bai R, Guo J, Ye XY, Xie Y, Xie T. Oxidative stress: The core pathogenesis and mechanism of Alzheimer's disease. Ageing Res Rev 2022; 77: 101619
- 29 Chen BX, Liu YN, Li HY. et al. Neuroprotective effect of puerarin on ischemic brain injury in mice by antioxidant stress. Chin J Clin Pharmacol 2021; 11: 1355-1357
- 30 Zhao SS, Yang WN, Jin H, Ma KG, Feng GF. Puerarin attenuates learning and memory impairments and inhibits oxidative stress in STZ-induced SAD mice. Neurotoxicology 2015; 51: 166-171
- 31 Zhou W, He H, Wei Q. et al. Puerarin protects against acetaminophen-induced oxidative damage in liver through activation of the Keap1/Nrf2 signaling pathway. Food Sci Nutr 2023; 11 (10) 6604-6615
- 32 Li R, Zheng N, Liang T, He Q, Xu L. Puerarin attenuates neuronal degeneration and blocks oxidative stress to elicit a neuroprotective effect on substantia nigra injury in 6-OHDA-lesioned rats. Brain Res 2013; 1517: 28-35
- 33 Zhang H, Liu Y, Lao M, Ma Z, Yi X. Puerarin protects Alzheimer's disease neuronal cybrids from oxidant-stress induced apoptosis by inhibiting pro-death signaling pathways. Exp Gerontol 2011; 46 (01) 30-37
- 34 Xu SJ, Jiang L, Xie B. et al. The role of miRNA in the pathogenesis of AD and its regulatory mechanism. Shijiazhuang: The First Hospital of Hebei Medical University; 2018
- 35 Xu SJ, Xie B, Zhang R. et al. Study on the regulatory mechanism of miRNAs in the pathogenesis of AD induced by oxidative stress. Shijiazhuang: The First Hospital of Hebei Medical University; 2015
- 36 Wang B, Ma W, Yang H. Puerarin attenuates hypoxia-resulted damages in neural stem cells by up-regulating microRNA-214. Artif Cells Nanomed Biotechnol 2019; 47 (01) 2746-2753
- 37 Liu F, Zhang Z, Zhang L. et al. Effect of metal ions on Alzheimer's disease. Brain Behav 2022; 12 (03) e2527
- 38 Peng Y, Chang X, Lang M. Iron homeostasis disorder and Alzheimer's disease. Int J Mol Sci 2021; 22 (22) 12442
- 39 Lee J, Hyun DH. The interplay between intracellular iron homeostasis and neuroinflammation in neurodegenerative diseases. Antioxidants 2023; 12 (04) 918
- 40 Zhang TC, Lin YC, Sun NN. et al. Icariin, astragaloside a and puerarin mixture attenuates cognitive impairment in APP/PS1 mice via inhibition of ferroptosis-lipid peroxidation. Neurochem Int 2024; 175: 105705
- 41 Dong XH, Chai XQ. Effects of epimedium herb, Astragalus membranaceus and Pueraria lobata on cerebral cortical neurons DMT1 and C in transgenic mice with Alzheimer's disease. Chin Minkang Med 2015; (14) 169
- 42 Wang DJ, He M. Protective effect of puerarin on damage induced by iron overload in human umbilical vein endothelial cells. J Nanchang Univ 2019; 59 (06) 6-8 (Med Sci)
- 43 Dey M, Singh RK. Neurotoxic effects of aluminium exposure as a potential risk factor for Alzheimer's disease. Pharmacol Rep 2022; 74 (03) 439-450
- 44 Yu J, Ding Y, Wu D, Liu P. Rutin, puerarin and silymarin regulated aluminum-induced imbalance of neurotransmitters and metal elements in brain of rats. Biol Trace Elem Res 2024; 202 (02) 548-557
- 45 Ren N. Effects of flavonoids on the regulation of neurotransmitters and the protection of antioxidant system in rats exposed to aluminum. Ji'nan: Shandong University; 2019
- 46 Cascella R, Cecchi C. Calcium dyshomeostasis in Alzheimer's disease pathogenesis. Int J Mol Sci 2021; 22 (09) 4914
- 47 Ren HW, Chen M, Wang HQ. et al. Puerarin reduces intracellular Ca2+ concentration and upregulates BDNF to protect hippocampal neurons in vascular dementia rats. Xi'an Jiaotong Daxue Xuebao Yixue Ban 2023; (02) 202-207
- 48 Lin F, Xin Y, Wang J. et al. Puerarin facilitates Ca(2+)-induced Ca(2+) release triggered by KCl-depolarization in primary cultured rat hippocampal neurons. Eur J Pharmacol 2007; 570 (1-3): 43-49
- 49 Wang K, Zhu X, Zhang K. et al. Neuroprotective effect of puerarin on glutamate-induced cytotoxicity in differentiated Y-79 cells via inhibition of ROS generation and Ca(2+) influx. Int J Mol Sci 2016; 17 (07) 1109
- 50 Hampel H, Mesulam MM, Cuello AC. et al. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. Brain 2018; 141 (07) 1917-1933
- 51 Liu CM, Zheng GH, Ming QL, Sun JM, Cheng C. Protective effect of puerarin on lead-induced mouse cognitive impairment via altering activities of acetyl cholinesterase, monoamine oxidase and nitric oxide synthase. Environ Toxicol Pharmacol 2013; 35 (03) 502-510
- 52 Koirala P, Seong SH, Jung HA, Choi JS. Comparative evaluation of the antioxidant and anti-alzheimer's disease potential of coumestrol and puerarol isolated from Pueraria lobata using molecular modeling studies. Molecules 2018; 23 (04) 785
- 53 Qiu ZK, Zhong DS, He JL, Liu X, Chen JS, Nie H. The anxiolytic-like effects of puerarin are associated with the changes of monoaminergic neurotransmitters and biosynthesis of allopregnanolone in the brain. Metab Brain Dis 2018; 33 (01) 167-175
- 54 Wu KJ, Lien JC, Wu CR. Puerarin attenuates cycloheximide-induced oxidative damage and memory-consolidation impairment in rats. J Integr Neurosci 2024; 23 (01) 17
- 55 Zhao ZH, Li AY, Guan CH. Effects of puerarin on behavior, monoamine transmitters and inflammation in rats with post-traumatic stress disorder based on IKK/IκBα/NF-κB pathway. Zhonghua Zhongyiyao Xuekan 2023; (11) 230-237
- 56 Mei ZG, Wang MZ, Liu XJ. et al. Effect of puerarin on mRNA expression of α7nAChR, NF-κBp65 and STAT3 in brain after cerebral ischemia-reperfusion in rats. Chin J Tradit Chin Med Pharm 2013; 28 (01) 113-117
- 57 Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell 2012; 148 (06) 1145-1159
- 58 Maruszak A, Żekanowski C. Mitochondrial dysfunction and Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35 (02) 320-330
- 59 Mi XX, Xu MC, Wang L. et al. Puerarin alleviates cadmium-induced mitochondrial structural damage and Pink1/Parkin-mediated mitophagy in neuronal cells of rats. Chin Vet Sci 2024; 54 (02) 276-281
- 60 Li J, Yang D, Li Z. et al. PINK1/Parkin-mediated mitophagy in neurodegenerative diseases. Ageing Res Rev 2023; 84: 101817
- 61 Wen S, Wang L, Wang T. et al. Puerarin alleviates cadmium-induced mitochondrial mass decrease by inhibiting PINK1-Parkin and Nix-mediated mitophagy in rat cortical neurons. Ecotoxicol Environ Saf 2022; 230: 113127
- 62 Wen SQ. Puerarin alleviates cadmium-induced neurotoxicity mediated by mitochondrial damage in rat cerebral cortical neurons. Yangzhou: Yangzhou University; 2024
- 63 Zhang WH. Puerarin alleviates oxidative damage and mitochondrial unfolded protein response induced by cadmium in rat neurocyte. Yangzhou: Yangzhou University; 2023
- 64 Peng F, Hu QP. A protective study of puerarin on hippocampal neurons in rats with pilocarpine epilepsy. J Anhui Med Univ 2020; 55 (12) 1888-1892
- 65 Huang XY, Xu MC, Zhang WH. et al. Protective effect of puerarin on mitochondrial damage caused by cadmium in the cerebral cortices of rat. Chin Vet Sci 2024; 54 (04) 560-565
- 66 Sun SC, Gong DF, Yuan TY. et al. Puerarin reduces oxidative damage to vascular endothelial cells by improving mitochondrial respiratory function. Yao Xue Xue Bao 2022; 57 (05) 1352-1360
- 67 Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther 2023; 8 (01) 267
- 68 Calsolaro V, Edison P. Neuroinflammation in Alzheimer's disease: Current evidence and future directions. Alzheimers Dement 2016; 12 (06) 719-732
- 69 Liu M, Meng QH, Guo H. et al. To investigate the effect of acetyl puerarin on the expression of microglia and PKC-δ in AD rats. J Shandong Second Med Univ 2013; 35 (01) 4-7
- 70 Li M, Meng HQ, Cai QY. et al. Effect of acetylpuerarin on expression of caspase-8 and caspase-3 in BV-2 mouse microglia cell line induced by Aβ(25–35). Basic Clin Med 2016; 36 (10) 1369-1373
- 71 Cai QY, Meng QH, Li M. et al. Effect of acetylpuerarin on the expression of NF-κBp65 and iNOS in BV-2 microglia cells induced by Aβ(25–35). Shenjing Jiepouxue Zazhi 2016; 32 (03) 397-402
- 72 Wang N, Zhang Y, Wu L. et al. Puerarin protected the brain from cerebral ischemia injury via astrocyte apoptosis inhibition. Neuropharmacology 2014; 79: 282-289
- 73 Dong LP, Han M, Yuan F, Xu LX, Wang TY. The protective effect of puerarin on cultured rat cerebral cortical astrocytes [in Chinese]. Chung Kuo Ying Yung Sheng Li Hsueh Tsa Chih 2001; 17 (02) 141-143
- 74 Zhou S, Li Y, Hong Y, Zhong Z, Zhao M. Puerarin protects against sepsis-associated encephalopathy by inhibiting NLRP3/Caspase-1/GSDMD pyroptosis pathway and reducing blood-brain barrier damage. Eur J Pharmacol 2023; 945: 175616
- 75 Zhou J, Zhang DD, Tao Y. et al. Puerarin attenuates the inflammatory response of vascular endothelial cells in KKAy mice. Basic Clin Med 2023; 43 (03) 433-437
- 76 Li XW, Wang Y, Han S. et al. Effects of puerarin on neurological function, and synaptic morphological structure and parameter of cerebral cortex in cerebral ischemia-reperfusion rats. Chin J Pathophysiol 2018; (11) 2043-2047
- 77 Huang XF, Chen Q, Ren Y. Effects of puerarin on the expressions of Bcl-2, Bax and Caspase-3 in the motor cortex of mice with traumatic brain injury. Clin J Chin Med 2019; (25) 13-15
- 78 Ma KP, Han S, Zhao SM. et al. Preventive protective effect of puerarin pretreatment on cerebral ischemia-reperfusion cerebral cortical microvessels and blood-brain barrier. Chin J Anat 2015; 38 (06) 694-697
- 79 Kim MH, Kim SH, Yang WM. Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimer's disease. Planta Med 2014; 80 (15) 1249-1258